相似文献
1
Left atrial appendage occlusion in Asia.
AsiaIntervention. 2019 Feb 20;5(1):15-17. doi: 10.4244/AIJV5I1A4. eCollection 2019 Feb.
2
Left Atrial Appendage Occlusion for Stroke Prevention in Nonvalvular Atrial Fibrillation.
J Am Heart Assoc. 2021 Nov 2;10(21):e022274. doi: 10.1161/JAHA.121.022274. Epub 2021 Oct 20.
3
Concomitant Surgical Left Atrial Appendage Occlusion: a Review.
Curr Cardiol Rep. 2022 Jul;24(7):823-828. doi: 10.1007/s11886-022-01705-5. Epub 2022 Apr 30.
4
Brain natriuretic peptide levels variation after left atrial appendage occlusion.
Catheter Cardiovasc Interv. 2016 Jan 1;87(1):E39-43. doi: 10.1002/ccd.25985. Epub 2015 May 29.
5
[CT Image-based Surgery Assist System for Left Atrial Appendage Occlusion].
Zhongguo Yi Liao Qi Xie Za Zhi. 2021 Jul 30;45(4):355-360. doi: 10.3969/j.issn.1671-7104.2021.04.001.
6
Percutaneous left atrial appendage occlusion: New perspectives for the method.
Cardiol J. 2017;24(5):554-562. doi: 10.5603/CJ.a2017.0029. Epub 2017 Mar 10.
7
Retrospective study assessing efficacy and safety of left atrial appendage occlusion.
Bratisl Lek Listy. 2020;121(9):609-618. doi: 10.4149/BLL_2020_100.
8
Percutaneous left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation and contraindication for anticoagulation.
Rev Neurol (Paris). 2015 May;171(5):426-32. doi: 10.1016/j.neurol.2014.11.009. Epub 2015 Apr 23.
9
Combined MitraClip implantation and left atrial appendage occlusion using the Watchman device: A case series from a referral center.
Rev Port Cardiol. 2017 Jul-Aug;36(7-8):525-532. doi: 10.1016/j.repc.2016.11.012. Epub 2017 Jun 30.
10
Left atrial appendage clip occlusion: early clinical results.
J Thorac Cardiovasc Surg. 2010 May;139(5):1269-74. doi: 10.1016/j.jtcvs.2009.06.033. Epub 2009 Nov 1.
本文引用的文献
1
Comparison of three left atrial appendage occlusion devices for stroke prevention in patients with non-valvular atrial fibrillation: a single-centre seven-year experience with WATCHMAN, AMPLATZER Cardiac Plug/Amulet, LAmbre: Comparison of three LAAO devices for stroke prevention.
AsiaIntervention. 2019 Feb;5(1):57-63. doi: 10.4244/AIJ-D-18-00013. Epub 2019 Feb 20.
2
Editorial commentary: Evolving technologies for percutaneous left atrial appendage occlusion.
Trends Cardiovasc Med. 2019 May;29(4):237-238. doi: 10.1016/j.tcm.2018.09.009. Epub 2018 Sep 18.
3
Combined atrial fibrillation ablation and left atrial appendage closure: long-term follow-up from a large multicentre registry.
Europace. 2018 Nov 1;20(11):1783-1789. doi: 10.1093/europace/euy025.
4
History of Percutaneous Left Atrial Appendage Occlusion with AMPLATZER Devices.
Interv Cardiol Clin. 2018 Apr;7(2):151-158. doi: 10.1016/j.iccl.2017.12.007.
5
A History of Percutaneous Left Atrial Appendage Occlusion with the PLAATO Device.
Interv Cardiol Clin. 2018 Apr;7(2):137-142. doi: 10.1016/j.iccl.2017.12.009.
6
Device-associated thrombus formation after left atrial appendage occlusion: A systematic review of events reported with the Watchman, the Amplatzer Cardiac Plug and the Amulet.
Catheter Cardiovasc Interv. 2017 Nov 1;90(5):E111-E121. doi: 10.1002/ccd.26903. Epub 2017 Feb 1.
7
Long-Term Persistence of Newly Initiated Warfarin Therapy in Chinese Patients With Nonvalvular Atrial Fibrillation.
Circ Cardiovasc Qual Outcomes. 2016 Jul;9(4):380-7. doi: 10.1161/CIRCOUTCOMES.115.002337. Epub 2016 Jul 5.
8
Left atrial appendage closure: patient, device and post-procedure drug selection.
EuroIntervention. 2016 May 17;12 Suppl X:X48-X54. doi: 10.4244/EIJV12SXA10.
9
Percutaneous left atrial appendage occlusion: the Munich consensus document on definitions, endpoints and data collection requirements for clinical studies.
EuroIntervention. 2016 May 17;12(1):103-11. doi: 10.4244/EIJV12I1A18.
10
Left atrial appendage occlusion with the AMPLATZER Amulet device: an expert consensus step-by-step approach.
EuroIntervention. 2016 Apr 20;11(13):1512-21. doi: 10.4244/EIJV11I13A292.
Zotero 插件